Reach Market Research

REACH is a Boston-based, independent pharmaceutical market research company focused on rare and niche diseases. With decades of experience in pharmaceutical market research and life sciences consulting, our team aims to fill an important gap in the market – accessible market research solutions for rare and niche diseases. We specialize in providing primary market research-driven market assessments, product profile assessments, and commercial insights for pipeline assets and marketed brands.

...Show More ...Show Less

36 Reports from Reach Market Research

Sort by:

Gout (Chronic Refractory)

Feb 23, 2024 | Published by: Reach Market Research | USD 17,150

MarketVue®: Chronic Refractory Gout The MarketVue®: Chronic Refractory Gout market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease over ... Read More
STXBP1 Encephalopathy

Feb 13, 2024 | Published by: Reach Market Research | USD 17,150

MarketVue®: STXBP1 Encephalopathy The MarketVue®: STXBP1 Encephalopathy market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiology ( ... Read More
Angelman Syndrome

Feb 09, 2024 | Published by: Reach Market Research | USD 17,150

MarketVue®: Angelman Syndrome The MarketVue®: Angelman Syndrome market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiology (US and E ... Read More
Tardive Dyskinesia (TD)

Jan 01, 2024 | Published by: Reach Market Research | USD 17,150

MarketVue®: Tardive Dyskinesia (TD) The MarketVue®: Tardive Dyskinesia (TD) market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease over ... Read More
Long QT Syndrome (LQTS)

Oct 06, 2023 | Published by: Reach Market Research | USD 17,150

MarketVue®: Long QT Syndrome (LQTS) The MarketVue®: Long QT Syndrome (LQTS) market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiolo ... Read More
Arrhythmogenic Cardiomyopathy (ACM)

Oct 06, 2023 | Published by: Reach Market Research | USD 17,150

MarketVue®: Arrhythmogenic Cardiomyopathy The MarketVue®: Arrhythmogenic Cardiomyopathy market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview ... Read More
Glycogen Storage Disease (GSD) Type 1a

Aug 29, 2023 | Published by: Reach Market Research | USD 17,150

MarketVue®: Glycogen Storage Disease Type 1a (GSD1a) The MarketVue®: Glycogen Storage Disease Type 1a market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a di ... Read More
Geographic Atrophy

Jul 14, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Geographic Atrophy (GA) The MarketVue®: Geographic Atrophy market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, ... Read More
Immunoglobulin A (IgA) Nephropathy

Jul 07, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Immunoglobulin A (IgA) Nephropathy The MarketVue®: IgA Nephropathy market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease o ... Read More
Graves' Disease

Jun 30, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Graves’ Disease The MarketVue®: Graves’ Disease market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiolo ... Read More
Atopic Dermatitis (Dupixent-Refractory)

Jun 08, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Dupixent-refractory atopic dermatitis (AD) The MarketVue®: Dupixent-refractory atopic dermatitis market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every M ... Read More
Membranous Nephropathy

Apr 21, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Membranous Nephropathy The MarketVue®: Membranous Nephropathy market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overvi ... Read More
Classical Homocystinuria

Mar 15, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Homocystinuria The MarketVue®: Homocystinuria market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiology (US and EU5), c ... Read More
Delayed Onset Type 1 Diabetes

Mar 01, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Delaying onset of Type 1 Diabetes The MarketVue®: delaying onset of Type 1 Diabetes market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® inc ... Read More
Generalized Pustular Psoriasis (GPP)

Mar 01, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Generalized Pustular Psoriasis (GPP) The MarketVue®: Generalized Pustular Psoriasis market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® inc ... Read More
Bullous Pemphigoid

Feb 01, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Bullous Pemphigoid The MarketVue®: Bullous Pemphigoid market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epid ... Read More
Frontal Fibrosing Alopecia

Jan 20, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Frontal Fibrosing Alopecia The MarketVue®: Frontal Fibrosing Alopecia market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a diseas ... Read More
Idiopathic Inflammatory Myopathies

Jan 01, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Idiopathic inflammatory myopathies (IIMs) The MarketVue®: Idiopathic inflammatory myopathies market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every Marke ... Read More
ANCA-Associated Vasculitis

Jan 01, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis The MarketVue®: ANCA-associated vasculitis market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the mar ... Read More
Pemphigus Vulgaris

Jan 01, 2023 | Published by: Reach Market Research | USD 12,250

MarketVue®: Pemphigus Vulgaris The MarketVue®: Pemphigus Vulgaris market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epid ... Read More
Myasthenia Gravis

Nov 23, 2022 | Published by: Reach Market Research | USD 12,250

MarketVue®: Myasthenia Gravis The MarketVue®: Myasthenia Gravis market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidem ... Read More
Pancreatic Ductal Adenocarcinoma (PDAC)

Nov 04, 2022 | Published by: Reach Market Research | USD 12,250

MarketVue®: Pancreatic Ductal Adenocarcinoma (PDAC) The MarketVue®: Pancreatic Ductal Adenocarcinoma (PDAC) market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every Ma ... Read More
Celiac Disease

Oct 28, 2022 | Published by: Reach Market Research | USD 12,250

MarketVue®: Celiac Disease The MarketVue®: Celiac Disease market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiology ... Read More
Eosinophilic Esophagitis

Oct 21, 2022 | Published by: Reach Market Research | USD 12,250

MarketVue®: Eosinophilic Esophagitis The MarketVue®: Eosinophilic Esophagitis market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease ov ... Read More
Netherton Syndrome

Oct 14, 2022 | Published by: Reach Market Research | USD 12,250

MarketVue®: Netherton’s Syndrome The MarketVue®: Netherton’s Syndrome market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiology (US ... Read More